Menu

Marc Recht

Partner

mrecht@cooley.com

full contact info

For over 20 years, Marc Recht has represented life sciences and other healthcare companies and investors in public and private transactions, including securities offerings, joint ventures and M&A matters. He also has extensive experience advising public companies boards of directors and management teams regarding Securities and Exchange Commission periodic disclosure, Sarbanes-Oxley compliance, corporate governance and Nasdaq and New York Stock Exchange rules.

Download full bio 

Experience

  • Exscientia Inks Investment of up to $525 Million 

  • Celularity to Go Public Through SPAC Merger 

  • Oncorus – $98 Million IPO 

  • RenalytixAI – $85 Million IPO 

  • Repare Therapeutics - $253 Million IPO 

  • View all

Practices & Industries
Passions

    Road cycling

    Skiing

Excellent in all categories. Marc Recht is 'very technically skilled in corporate matters and plays a strong quarterback role.' – Legal 500 (2013)
Education

  • Boston College Law School
    JD, magna cum laude, 1999

  • Brandeis University
    BA, with honors, 1995

Admissions & Credentials

Massachusetts

Media & Insight
Rankings & Accolades

    Chambers USA: Capital Markets –Massachusetts (2014-2021)

    The Legal 500 US: Healthcare: Life Sciences (2013, 2016, 2020)

    Who's Who Legal: Life Sciences (2017, 2018)

    Super Lawyers: Rising Star (2007, 2010 – 2013)

    Boston Business Journal: Biotech IPO (2015)


Contact

mrecht@cooley.com

+1 617 937 2316

Locations